Standard Chemical & Pharmaceutical Co. Ltd. (TPE: 1720)

Standard Chemical & Pharmaceutical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	6,611	6,240	5,851	4,604	4,305	3,937
Revenue Growth (YoY)	7.76%	6.64%	27.09%	6.94%	9.35%	10.19%
Cost of Revenue	3,712	3,514	3,364	2,536	2,386	2,228
Gross Profit	2,900	2,725	2,488	2,068	1,920	1,709
Selling, General & Admin	1,267	1,209	1,100	948.47	992.48	973.56
Research & Development	286.49	266.27	251.88	241.79	227.21	225.77
Operating Expenses	1,558	1,466	1,369	1,191	1,213	1,194
Operating Income	1,342	1,260	1,118	876.83	706.63	515.59
Interest Expense	-21.5	-25.42	-18.78	-7.25	-7.57	-10.47
Interest & Investment Income	63.97	76.84	39.45	24.99	26.52	30.73
Earnings From Equity Investments	18.03	41.56	61.37	-6.16	3.05	1.75
Currency Exchange Gain (Loss)	65.04	5.62	170.44	-25.6	-33.07	-28.93
Other Non Operating Income (Expenses)	43.19	30.1	35.44	77.66	77.29	89.36
EBT Excluding Unusual Items	1,510	1,388	1,406	940.47	772.85	598.03
Gain (Loss) on Sale of Investments	4.55	5.53	1.36	1.46	0.2	-3.46
Gain (Loss) on Sale of Assets	0.92	1.27	-7.78	73.78	-0.08	-9.02
Asset Writedown	-	-	-	-1.81	-	-
Other Unusual Items	0.02	0.02	0.11	-66.45	-0.04	0.26
Pretax Income	1,516	1,438	1,400	1,014	772.93	585.81
Income Tax Expense	312.29	279.94	246.31	176.95	147.37	115.38
Earnings From Continuing Operations	1,204	1,158	1,154	836.8	625.56	470.43
Net Income to Company	1,204	1,158	1,154	836.8	625.56	470.43
Minority Interest in Earnings	-349.52	-323.04	-338.21	-130.07	-101.39	-93.95
Net Income	854.07	834.89	815.41	706.73	524.17	376.48
Net Income to Common	854.07	834.89	815.41	706.73	524.17	376.48
Net Income Growth	-1.01%	2.39%	15.38%	34.83%	39.23%	0.57%
Shares Outstanding (Basic)	179	179	179	179	179	179
Shares Outstanding (Diluted)	179	179	179	179	179	179
Shares Change (YoY)	-0.01%	0.00%	-0.02%	0.02%	0.01%	-0.01%
EPS (Basic)	4.78	4.67	4.56	3.95	2.93	2.11
EPS (Diluted)	4.78	4.67	4.56	3.95	2.93	2.10
EPS Growth	-0.84%	2.41%	15.44%	34.81%	39.52%	0.48%
Free Cash Flow	683.67	710.83	31.78	613.56	570.06	474.71
Free Cash Flow Per Share	3.82	3.97	0.18	3.43	3.19	2.65
Dividend Per Share	2.700	2.700	2.500	2.500	1.800	1.500
Dividend Growth	8.00%	8.00%	0%	38.89%	20.00%	0%
Gross Margin	43.86%	43.68%	42.51%	44.91%	44.59%	43.41%
Operating Margin	20.29%	20.19%	19.11%	19.04%	16.41%	13.10%
Profit Margin	12.92%	13.38%	13.94%	15.35%	12.17%	9.56%
Free Cash Flow Margin	10.34%	11.39%	0.54%	13.33%	13.24%	12.06%
EBITDA	1,695	1,579	1,389	1,073	917.22	722.14
EBITDA Margin	25.63%	25.30%	23.74%	23.31%	21.30%	18.34%
D&A For EBITDA	353.02	319.44	270.67	196.31	210.59	206.56
EBIT	1,342	1,260	1,118	876.83	706.63	515.59
EBIT Margin	20.29%	20.19%	19.11%	19.04%	16.41%	13.10%
Effective Tax Rate	20.60%	19.47%	17.59%	17.45%	19.07%	19.70%

Source: S&P Capital IQ. Standard template. Financial Sources.